Various ACREDIT members participated in the PSOGI 2016 International congress held 17-19 November 2016 in Washington, D.C. Yvonne Andersson (pictured right), presented a poster showing results from the Immunotoxin in Peritoneal Carcinomatosis (ImmunoPeCa) phase I trial, which is a novel intraperitoneal treatment for peritoneal metastases after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Annette and Christin (also pictured, right) presented a poster with the title “In-depth mutation analysis of pseudomyxoma peritonei (PMP) patient samples with low tumor content”. They showed that it is possible to identify mutations in PMP patient samples with extremely low tumor content using ultra-deep targeted sequencing, with KRAS and GNAS as the most frequently mutated genes.
There were over 680 participants from 54 countries at the PSOGI conference, and this year’s program was very successful due to presentations from expert faculty, engaging and interactive panel discussions, evening programs and active participation from all of the attendees throughout the 3 day program. From Oslo University Hospital various researchers and clinicians attended the meeting.